The global market for cell therapies shows no sign of slowing down.
Whether it's CAR-T cells for cancer therapy, gene therapy applications, or another infusion of living cells, developing cell products comes with novel challenges in developing, testing, and manufacturing them. Even though a “one-size-fits-all” approach doesn’t work for developing cell therapies, as each are unique, there are common considerations you should be mindful of.
Learn about the most essential steps and tools to help optimize your cell therapy.
David Harris, PhD
Sanne Holt, PhD
Dominic Clarke, PhD
Global Head of Cell Therapy
HemaCare, A Charles River Company
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.